ArticleJBMR plus2026

Differential effects of romosozumab across central and peripheral skeletal sites: a prospective DXA and HR-pQCT study in high-risk postmenopausal osteoporosis.

Ko Chiba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.